Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02057770
Title Allogeneic or Haploidentical Stem Cell Transplant Followed By High-Dose Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

acute myeloid leukemia

Therapies

Busulfan + Cyclophosphamide + Fludarabine

Tocilizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.